Pre-market Movers For Sept 3 (MSFT, TSLA, CYTK, ISIS)

(RTTNews) - Gainers:

Isis Pharmaceuticals, Inc. (ISIS) is up 5 percent to $27.10. The company announced interim data from an ongoing Phase 2 study of ISIS-APOCIIIRx as a monotherapy in patients with very high to severely high triglycerides. In this study, patients treated with ISIS-APOCIIIRx achieved statistically significant mean reductions of up to 79 percent in apolipoprotein C-III (apoC-III) and up to 75 percent in triglycerides.

Tesla Motors, Inc. (TSLA) is gaining 3 percent to $173.75.

Decliners:

Microsoft Corp. (MSFT) is down 5 percent to $31.75. The company has agreed to buy substantially all the Devices & Services business from Nokia Corp. (NOK). The software giant will also license Nokia's patents and license, and use Nokia's mapping services for a total cost of 5.44 billion euros in cash.

Cytokinetics, Inc. (CYTK) is falling 20 percent to $8.40. The company announced that phase II trial evaluating its drug candidate Omecamtiv mecarbil in intravenous formulation as a potential treatment of heart failure, dubbed ATOMIC-AHF, has failed to meet its primary endpoint of dyspnea, while showing favorable dose and concentration-related trends on dyspnea response.